Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors

Oncogene

Volumn 29, Issue 22, 2010, Pages 3185-3195

  Van Eekelen, M ^a   Sasportas, L S ^a   Kasmieh, R ^a   Yip, S ^a,b   Figueiredo, J L ^a   Louis, D N ^a,b   Weissleder, R ^a   Shah, K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Brain tumor; Endothelial cells; Glioma; Human neural stem cells; In vivo imaging; TSP 1

Indexed keywords

THROMBOSPONDIN 1; ANGIOGENESIS INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN TUMOR; CELL BASED GENE THERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR VASCULARIZATION; ANIMAL; BIOSYNTHESIS; BRAIN NEOPLASMS; CELL CULTURE; CELL GROWTH; CYTOLOGY; DISEASE MODEL; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GLIOMA; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENETIC ENGINEERING; GLIOMA; HUMANS; MICE; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS; THROMBOSPONDIN 1; TRANSDUCTION, GENETIC;

MUS;

EID: 77953232760     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.75     Document Type: Article

References (37)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W et al. (2000). Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97: 12846-12851.
2. Anderson JC, Grammer JR, Wang W, Nabors LB, Henkin J, Stewart Jr JE et al. (2007). ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis. Cancer Biol Ther 6: 454-462.
3. Asaishi K, Endrich B, Gotz A, Messmer K. (1981). Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res 41: 1898-1904.
4. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS et al. (2007). AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11: 83-95.
5. Bergers G, Benjamin LE. (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
6. Bogdanov Jr A, Marecos E, Cheng HC, Chandrasekaran L, Krutzsch HC, Roberts DD et al. (1999). Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study. Neoplasia 1: 438-445.
7. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
8. Capillo M, Mancuso P, Gobbi A, Monestiroli S, Pruneri G, DellAgnola C et al. (2003). Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin Cancer Res 9: 377-382.
9. Carmeliet P, Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature 407: 249-257.
10. Corsten MF, Shah K. (2008). Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol 9: 376-384.
11. Drixler TA, Borel Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE. (2000). Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60: 1761-1765.
12. Duda DG, Batchelor TT, Willett CG, Jain RK. (2007). VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med 13: 223-230.
13. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL et al. (2002). Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62: 7170-7174.
14. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. (2004). Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 1: 165-176.
15. Guerin C, Laterra J. (1997). Regulation of angiogenesis in malignant gliomas. Exs 79: 47-64.
16. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
17. Hoekstra R, de Vos FY, Eskens FA, de Vries EG, Uges DR, Knight R et al. (2006). Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination. Eur J Cancer 42: 467-472.
18. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. (2007). Angiogenesis in brain tumors. Nat Rev Neurosci 8: 610-622.
19. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E et al. (2001). Continuous administration of endostatin by intra-peritoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61: 7669-7674.
20. Kock N, Kasmieh R, Weissleder R, Shah K. (2007). Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 9: 435-442.
21. Lawler J, Detmar M. (2004). Tumor progression: the effects of thrombospondin-1 and-2. Int J Biochem Cell Biol 36: 1038-1045.
22. Liu P, Wang Y, Li YH, Yang C, Zhou YL, Li B et al. (2003). Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice. Leuk Res 27: 701-708.
23. Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA et al. (2007). A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am J Clin Oncol 30: 303-309.
24. Montet X, Figueiredo JL, Alencar H, Ntziachristos V, Mahmood U, Weissleder R. (2007). Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology 242: 751-758.
25. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382-11388.
26. Papetti M, Herman IM. (2002). Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970.
27. Rusk A, McKeegan E, Haviv F, Majest S, Henkin J, Khanna C. (2006). Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res 12: 7444-7455.
28. Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G et al. (2009). Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 106: 4822-4827.
29. Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R et al. (2005). Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57: 34-41.
30. Shah K, Hingtgen S, Kasmieh R, Figueiredo JL, Garcia-Garcia E, Martinez-Serrano A et al. (2008). Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci 28: 4406-4413.
31. Shah K, Tang Y, Breakefield X, Weissleder R. (2003). Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22: 6865-6872.
32. Shah K, Tung CH, Yang K, Weissleder R, Breakefield XO. (2004). Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res 64: 3236-3242.
33. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield X, Weissleder R. (2003). in vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 14: 1247-1254.
34. Tuettenberg J, Friedel C, Vajkoczy P. (2006). Angiogenesis in malignant glioma\a target for antitumor therapy? Crit Rev Oncol Hematol 59: 181-193.
35. Verhaegent M, Christopoulos TK. (2002). Recombinant gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal Chem 74: 4378-4385.
36. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ et al. (2000). Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80: 837-849.
37. Zhang X, Connolly C, Duquette M, Lawler J, Parangi S. (2007). Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Lett 247: 143-149.